Atyr Pharma, Stock Buy Hold or Sell Recommendation
| ATYR Stock | 3.44 0.15 4.56% |
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding aTyr Pharma, is 'Strong Buy'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell aTyr Pharma, given historical horizon and risk tolerance towards ATyr Pharma,. When Macroaxis issues a 'buy' or 'sell' recommendation for aTyr Pharma,, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out ATyr Pharma, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in ATyr Stock, please use our How to Invest in ATyr Pharma, guide. Note, we conduct extensive research on individual companies such as ATyr and provide practical buy, sell, or hold advice based on investors' constraints. aTyr Pharma,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
ATyr |
Execute ATyr Pharma, Buy or Sell Advice
The ATyr recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on aTyr Pharma,. Macroaxis does not own or have any residual interests in aTyr Pharma, or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute ATyr Pharma,'s advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Solid | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
ATyr Pharma, Trading Alerts and Improvement Suggestions
| aTyr Pharma, appears to be risky and price may revert if volatility continues | |
| aTyr Pharma, was previously known as ATyr Pharma and was traded on NASDAQ Exchange under the symbol LIFE. | |
| The company reported the previous year's revenue of 353 K. Net Loss for the year was (50.39 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ATyr Pharma, generates negative cash flow from operations | |
| aTyr Pharma, has a frail financial position based on the latest SEC disclosures | |
| About 64.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: aTyr Pharma stock rated Buy Lucid notes Efzofitimods potential in lung diseases - Investing.com |
ATyr Pharma, Returns Distribution Density
The distribution of ATyr Pharma,'s historical returns is an attempt to chart the uncertainty of ATyr Pharma,'s future price movements. The chart of the probability distribution of ATyr Pharma, daily returns describes the distribution of returns around its average expected value. We use aTyr Pharma, price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of ATyr Pharma, returns is essential to provide solid investment advice for ATyr Pharma,.
| Mean Return | 1.03 | Value At Risk | -4.81 | Potential Upside | 8.76 | Standard Deviation | 4.71 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of ATyr Pharma, historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
ATyr Pharma, Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ATyr Pharma, or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ATyr Pharma,'s price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ATyr stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.94 | |
β | Beta against Dow Jones | 0.75 | |
σ | Overall volatility | 4.77 | |
Ir | Information ratio | 0.19 |
ATyr Pharma, Volatility Alert
aTyr Pharma, shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure ATyr Pharma,'s stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact ATyr Pharma,'s stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.ATyr Pharma, Fundamentals Vs Peers
Comparing ATyr Pharma,'s fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ATyr Pharma,'s direct or indirect competition across all of the common fundamentals between ATyr Pharma, and the related equities. This way, we can detect undervalued stocks with similar characteristics as ATyr Pharma, or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ATyr Pharma,'s fundamental indicators could also be used in its relative valuation, which is a method of valuing ATyr Pharma, by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare ATyr Pharma, to competition |
| Fundamentals | ATyr Pharma, | Peer Average |
| Return On Equity | -0.62 | -0.31 |
| Return On Asset | -0.33 | -0.14 |
| Operating Margin | (106.33) % | (5.51) % |
| Current Valuation | 79.38 M | 16.62 B |
| Shares Outstanding | 75.8 M | 571.82 M |
| Shares Owned By Insiders | 2.39 % | 10.09 % |
| Shares Owned By Institutions | 64.48 % | 39.21 % |
| Number Of Shares Shorted | 2.11 M | 4.71 M |
| Price To Book | 1.76 X | 9.51 X |
| Price To Sales | 244.92 X | 11.42 X |
| Revenue | 353 K | 9.43 B |
| EBITDA | (52.18 M) | 3.9 B |
| Net Income | (50.39 M) | 570.98 M |
| Total Debt | 15.1 M | 5.32 B |
| Book Value Per Share | 1.08 X | 1.93 K |
| Cash Flow From Operations | (33.22 M) | 971.22 M |
| Short Ratio | 1.47 X | 4.00 X |
| Earnings Per Share | (0.90) X | 3.12 X |
| Target Price | 22.0 | |
| Number Of Employees | 56 | 18.84 K |
| Beta | 1.21 | -0.15 |
| Market Capitalization | 144.01 M | 19.03 B |
| Total Asset | 120.65 M | 29.47 B |
| Retained Earnings | (468.02 M) | 9.33 B |
| Working Capital | 86.58 M | 1.48 B |
| Net Asset | 120.65 M |
Note: Acquisition by Schimmel Paul of 52300 shares of ATyr Pharma, at 1.9319 subject to Rule 16b-3 [view details]
ATyr Pharma, Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ATyr . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About ATyr Pharma, Buy or Sell Advice
When is the right time to buy or sell aTyr Pharma,? Buying financial instruments such as ATyr Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having ATyr Pharma, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Realty Funds Thematic Idea Now
Realty Funds
Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. The Realty Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Realty Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for ATyr Stock Analysis
When running ATyr Pharma,'s price analysis, check to measure ATyr Pharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma, is operating at the current time. Most of ATyr Pharma,'s value examination focuses on studying past and present price action to predict the probability of ATyr Pharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma,'s price. Additionally, you may evaluate how the addition of ATyr Pharma, to your portfolios can decrease your overall portfolio volatility.